News & Press Releases

Filter
440 found

New Partnership launched to accelerate elimination of relapsing P. vivax malaria that poses a risk to an estimated 2.5 billion people worldwide

14 Jul 2021
Access & product management

Pyronaridine-artesunate demonstrates high real-life safety, tolerability and effectiveness in the treatment of uncomplicated malaria in large multi-country study in Africa

17 Jun 2021
R&D

MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development

31 May 2021
R&D

MMV and DNDi urge WHO member states to invest in medicines for women and children

27 May 2021
General

MMV and partners recognize malaria innovations and urge WHO member states to scale up investments

26 May 2021
General

MMV deeply saddened by the loss of Ambassador Dr Konji Sebati

18 May 2021
General

MMV recognizes partner Novartis’ milestone of 1 billion courses of antimalarial delivered

18 May 2021
Partner

SMC scale-up significantly reduces child mortality in the Sahel

10 May 2021
Access & product management

MMV’s partner S Kant receives WHO prequalification for its protective medicine for children

23 Apr 2021
Access & product management

This World Malaria Day MMV recognizes Swiss Malaria Group's commitment to defeating malaria

19 Apr 2021
Partner

MMV mourns the loss of Professor Sir Colin Dollery

29 Jan 2021
General

New report demonstrates how R&D partnerships serving neglected communities have developed dozens of life-saving innovations since 2010

28 Jan 2021
R&D

Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel

28 Jan 2021
Access & product management

GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

08 Jan 2021
Access & product management

MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling

18 Dec 2020
R&D

Looking Back at An Extraordinary Year

18 Dec 2020
General

MMV’s Adam Aspinall appointed as Chair of the new Fight the Fakes Alliance

14 Dec 2020
Access & product management

MMV supports the launch of the new Fight the Fakes Alliance

07 Dec 2020
Access & product management

World Malaria Report highlights two decades of progress while calling for increased commitment as gains plateau

30 Nov 2020
General

Largest clinical trial in Africa to treat COVID-19 cases before they become severe

20 Nov 2020
R&D

GSK and MMV present positive data on treatment of Plasmodium vivax malaria

19 Nov 2020
R&D

Endemic countries in South America meet to discuss new tools for malaria elimination

02 Nov 2020
Partner

Global call to boost access to lifesaving malaria treatment for pregnant women in Africa

15 Oct 2020
Partner

Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria

19 Aug 2020
R&D, General

MMV awards Project of the Year 2019 to Novartis for the discovery of INE963

13 Jul 2020
R&D

MMV launches Malaria Libre, a new open source drug discovery programme

07 Jul 2020
R&D

ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame

30 Jun 2020
R&D, General

MMV deeply saddened by the loss of Dr Ricardo Thompson

26 Jun 2020
General

MMV’s Dr James Duffy appointed to RSC Lectureship

19 Jun 2020
R&D

MMV launches the COVID Box to stimulate new drug research

10 Jun 2020
R&D, Open source

MMV submits statement to 73rd World Health Assembly

19 May 2020
General

This World Malaria Day MMV supports Swiss Malaria Group's call for urgent action

25 Apr 2020
Partner

Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria

24 Apr 2020
Access & product management

In support of the COVID-19 response

31 Mar 2020
General

MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy

08 Mar 2020
R&D, Partner

International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa

03 Mar 2020
R&D

Malaria continues to strike pregnant women and children hardest and new tools are critical, according to WHO’s latest report

05 Dec 2019
General
Laboratory image

Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million

27 Nov 2019
R&D, Partner

MMV presents Lifetime Achievement Awards to three longstanding collaborators

25 Nov 2019
Partner

Country leaders pledge to boost malaria innovation and access to new and existing antimalarials

11 Nov 2019
Partner

Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of P. vivax malaria

30 Oct 2019
Access & product management

MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria

22 Oct 2019
General

WHO issues information note about Pyramax® (artesunate-pyronaridine) for uncomplicated malaria

09 Oct 2019
General

MMV contributes to the fight against schistosomiasis

30 Sep 2019

Via Grand Challenges Africa, MMV supports eight African drug discovery scientists

23 Sep 2019
R&D

Two reports on malaria eradication underline need for new tools and interventions

09 Sep 2019
General

MMV awards its Project of the Year 2018 to University of Dundee researchers

10 Jul 2019
R&D

MMV launches new P. vivax malaria information hub

26 Jun 2019
Access & product management

Life-saving malaria project in Zambia to expand

25 Apr 2019
General

Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention

24 Apr 2019
R&D

MMV participates in Swiss World Malaria Day event

24 Apr 2019
General

PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria

23 Apr 2019
Access & product management
Photo: Anna Wang/MMV

Europe-Africa partnership spearheads development of next-generation antimalarial drug

15 Apr 2019

MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases

29 Jan 2019
R&D, Open source

Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine

16 Jan 2019
R&D

Professor Michael Ferguson receives Knighthood in New Year’s Honours List

14 Jan 2019
R&D

2018 - A triumph of partnerships

19 Dec 2018
General

Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria

07 Dec 2018
R&D

Access to Medicines Index highlights role of collaboration in stimulating R&D

21 Nov 2018
R&D, Access & product management

Fosun Pharma’s medicine to protect pregnant women from malaria first to be approved by WHO

19 Nov 2018
Partner, Access & product management

Pages